Skip to main content
    E

    Evotec SE ADR (EVO)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $1.48
    -0.08 (-5.13%)

    Market Cap: $561.51M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Evotec SE ADR (EVO) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Evotec SE ADR (EVO) has a market cap of $561.51M. It kept -25.37% of revenue as net income over the last 12 months.

    Total Valuation

    Market Cap$561.51M
    Latest price (Nov 17, 2026)$1.48

    Key Dates

    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count held steady in the quarter ended Sep 30, 2026 and grew 0.12% a year over 2 years.

    Shares Outstanding355.53M
    Shares Change (YoY)+0.05%
    Shares Change (QoQ)0.00%
    Share Count Growth (2Y CAGR)+0.12%

    Valuation Ratios

    Sales and book value multiples are 0.6x and 0.7x. Its year-end P/S ranged from 0.9x to 4.9x from 2022 to 2025.

    P/S Ratio0.6x
    P/B Ratio0.7x
    P/TBV Ratio1.4x

    Valuation history and multiples

    Price Statistics

    The stock is down 50.99% over 52 weeks and trades 6.33% below its 50-day average.

    Beta (1Y)1.15
    52-Week Change-50.99%
    1-Month Change+4.23%
    3-Month Change-25.25%
    6-Month Change-46.76%
    5-Year Change-93.63%
    10-Year Change-43.65%
    Total Return (1Y)-50.99%
    Total Return (3Y CAGR)-47.25%
    Total Return (5Y CAGR)-42.77%
    Return vs SPY (1Y)-61.56%
    Max Drawdown (1Y)-65.25%
    Max Drawdown (3Y)-88.69%
    Sharpe Ratio (1Y)-1.23
    Correlation with SPY (1Y)0.28
    50-Day Average$1.58
    200-Day Average$2.40
    52-Week Range$1.33 to $3.87
    RSI (14 Days)41.1
    Average Volume (20 Days)73.47K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.32x current liabilities, and total debt is 0.65x shareholder equity.

    Current Ratio2.32x
    Quick Ratio2.19x
    Debt / Equity0.65x
    Interest Coverage-11.83x

    Returns and Efficiency

    Return on invested capital is -15.11% over the last 12 months, against a 5-year average of -3.20%.

    Return on Equity (ROE)-28.95%
    Return on Assets (ROA)-12.34%
    Return on Invested Capital (ROIC)-15.11%
    Return on Capital Employed (ROCE)-12.99%
    ROE (5Y Average)-7.89%
    ROA (5Y Average)-3.53%
    ROIC (5Y Average)-3.20%
    Asset Turnover0.44x
    Inventory Turnover16.69x
    Receivables Turnover6.16x
    Cash Conversion Cycle53 days

    Scores

    EVO has an Altman Z-Score of -0.14, in the distress zone below 1.81, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Altman Z-Score-0.14
    Altman Z ZoneDistress
    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of EUR 723.27M over the last 12 months is down 4.37% from the 12 months before.

    RevenueEUR 723.27M
    Revenue Growth (YoY)-4.37%
    Gross ProfitEUR 95.06M
    Operating IncomeEUR -98.23M
    Pretax IncomeEUR -165.67M
    Net IncomeEUR -183.48M
    EBITEUR -158.44M

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 42.78% of the EUR 1.50B in total assets.

    Working CapitalEUR 377.62M
    Shareholder EquityEUR 641.66M
    Tangible Book ValueEUR 334.43M
    Total AssetsEUR 1.50B
    Total LiabilitiesEUR 863.31M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After EUR 37.08M of capital spending, operating cash flow left EUR -129.77M of free cash flow.

    Operating Cash FlowEUR -92.69M
    Capital ExpendituresEUR 37.08M
    Free Cash FlowEUR -129.77M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -13.58%, against a 5-year average of -8.01%.

    Gross Margin13.14%
    Operating Margin-13.58%
    Pretax Margin-22.91%
    Net Margin-25.37%
    EBIT Margin-21.91%
    FCF Margin-17.94%
    Gross Margin (5Y Average)18.56%
    Operating Margin (5Y Average)-8.01%
    Net Margin (5Y Average)-7.40%

    Growth

    Revenue grew 0.26% a year over 3 years.

    Revenue Growth (3Y CAGR)+0.26%
    Revenue Growth (5Y CAGR)+8.62%

    Revenue and profit by year

    Stock Splits

    The last split was a 4-for-1 forward split on Oct 20, 2021.

    Last Split DateOct 20, 2021
    Split TypeForward split
    Split Ratio4:1

    Peer Position

    Against 10 similar companies, EVO has the 9th highest P/S.

    P/S Ratio0.6x vs 1.8x median
    ROIC-15.11% vs 1.48% median
    Revenue Growth (Trailing 4 Quarters, YoY)-4.37% vs +13.87% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About EVO

    What is EVO's market cap?

    Evotec SE ADR has a market cap of $561.51M.

    How many shares of EVO are outstanding?

    Evotec SE ADR has 355.53M shares outstanding. The count is up 0.05% from a year earlier.

    Does EVO pay a dividend?

    No. Evotec SE ADR does not pay a dividend.